TransCode Therapeutics Inc. Company Profile
NASDAQ: RNAZHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.71-0.05 (-2.84%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
TransCode Therapeutics at a glance
TransCode Therapeutics Inc. (NASDAQ: RNAZ) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $30.1 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001829635, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- TransCode Therapeutics Inc.
- Ticker
- NASDAQ: RNAZ
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2021
- Market cap
- $30.14M
- SEC CIK
- 0001829635
Companies similar to TransCode Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MIRAMIRA Pharmaceuticals Inc. | 0.703 | -0.99% | $29.54M | vs RNAZ |
| NXTCNextCure Inc. | 6.78 | +3.35% | $31.03M | vs RNAZ |
| IGCIGC Pharma Inc. | 0.2824 | +0.86% | $29.20M | vs RNAZ |
| IMMPImmutep Limited ADR | 3.84 | -6.56% | $28.30M | vs RNAZ |
| RMTIRockwell Medical Inc. | 8.02 | -2.43% | $32.32M | vs RNAZ |
| CNTXContext Therapeutics Inc. | 0.299 | -4.34% | $27.47M | vs RNAZ |
| NNVCNanoViricides Inc. | 1.31 | -9.03% | $33.44M | vs RNAZ |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.08 | +0.47% | $33.80M | vs RNAZ |